Boc-Hyp-OH
(2S,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid

Produktübersicht
Kurzüberblick
- Produktfamilie
- ADC Linkers & Conjugation Reagents
- Chemischer Name
- (2S,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid
- MF
- C10H17NO5
- MW
- 231.25
Boc-Hyp-OH is a Boc-protected hydroxyproline derivative.
CAS 13726-69-7, molecular formula C10H17NO5, molecular weight 231.25, and PubChem CID 88804 match this CH53004 record.
The PubChem IUPAC name identifies the stereochemistry as (2S,4R).
Identität und Spezifikationen
| Catalog No. | CH53004 |
| CAS No. | 13726-69-7 |
| Chemical Name | (2S,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid |
| Molecular Formula | C10H17NO5 |
| Molecular Weight | 231.25 |
| PubChem CID | 88804 |
Zugehörige technische Ressourcen
Öffentliche Quellen
- (2S,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid | PubChem CID 88804
- Development of Solid-Phase Site-Specific Conjugation and Its Application toward Generation of Dual Labeled Antibody and Fab Drug Conjugates
Bioconjugate Chemistry, 2016
Product-family technical context
- Effect of Linker-Drug Properties and Conjugation Site on the Physical Stability of ADCs
Journal of Pharmaceutical Sciences, 2020
Product-family technical context
- Antibody-Maytansinoid Conjugates Are Activated in Targeted Cancer Cells by Lysosomal Degradation and Linker-Dependent Intracellular Processing
Cancer Research, 2006
Product-family technical context
- The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates
Molecular Cancer Therapeutics, 2012
Product-family technical context
Häufig gestellte Fragen
What is Boc-Hyp-OH?
Boc-Hyp-OH is a Boc-protected hydroxyproline derivative.
Ähnliche Produkte
Benötigen Sie Hilfe bei der Materialauswahl?
CHEMOS kann Produktfit, Zielstruktur, Routenfragen, analytische Erwartungen und projektspezifische Lieferbedarfe prüfen.



